Medical MisinformationNCT07601308
Impact of Online Medical Misinformation
An observational study of Medical Misinformation and Medication Adherence, run by Alexandria University at 1 site in Egypt.
Trial summary
A cross-sectional analytical study was conducted among adult patients diagnosed with chronic diseases to assess the impact of online medical misinformation on medication adherence, treatment decision-making, and health care-seeking behavior. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Medical Misinformation, Medication Adherence, Health-Seeking Behavior
- What is being tested?
- None (observational)
- How many people
- 402 participants
- Where
- 1 siteEgypt
- Study dates
- 20 May 2026to 30 Jul 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients with chronic diseases attending outpatient clinics, who actively use social media and are exposed to online medical information.
Who may be able to join
- Adults ≥ 18 years
- Disease duration ≥ 6 months
- Social media use at least once weekly
- Able to provide informed consent
Who cannot join
- Severe cognitive or psychiatric disorders
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Faculty of Nursing, Alexandria University
Alexandria, Alexandria Governorate, 21511
About this study
Official title: Online Health Misinformation and Its Association With Medication Adherence, Treatment Decision-making, and Health Care-Seeking Behavior Among Patients With Chronic Diseases: A Cross-sectional Study
A cross-sectional analytical study was conducted among adult patients diagnosed with chronic diseases to assess the impact of online medical misinformation on medication adherence, treatment decision-making, and health care-seeking behavior.
- Conditions
- Medical Misinformation, Medication Adherence, Health-Seeking Behavior, Chronic Diseases, Diabetes (DM), Hypertension (HTN)
- Being tested
- None (observational)
- Keywords
- Online Misinformation, Chronic Disease, Medication Adherence
- Medical subject headings
- Medication Adherence, Health Behavior, Chronic Disease, Diabetes Mellitus, Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
None (observational)Other
None (observational)
| Study group | Role | What they receive |
|---|---|---|
| Single Cohort: Adults With Chronic Diseases Exposed to Online Medical Information | Not described Receives: Other: None (observational) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Medication Adherence (MARS-5 Score)
Description: Measures adherence to prescribed medications
Measured: At baseline survey assessment
Healthcare-Seeking Behavior Score
Measured: At baseline survey assessment
Treatment Decision Changes (OHIU-CD Subscale)
Measures changes in treatment decisions influenced by online information
Measured: At baseline survey assessment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 May 2026
- Study start20 May 2026
- Primary completion30 Jun 2026
- Study completion30 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medical MisinformationStudies of the same condition, open and under way.
- More trials run by Alexandria UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 402 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alexandria University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Fakhry Ahmed Salem, Alexandria University
- Investigators
- Mohamed Fakhry Ahmed Salem, PHD, Principal investigator, Alexandria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07601308
- Sponsor's protocol ID
- AU-20-10-476
- Status last verified
- May 2026
- First submitted
- 9 May 2026
- Last updated
- 13 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Online Health Misinformation and Its Association With Medication Adherence, Treatment Decision-making, and Health Care-Seeking Behavior Among Patients With Chronic Diseases: A Cross-sectional Study
- ClinicalTrials.gov ID
- NCT07601308
- Acronym / sponsor ID
- AU-20-10-476
- Conditions
- Medical Misinformation, Medication Adherence, Health-Seeking Behavior, Chronic Diseases, Diabetes (DM), Hypertension (HTN)
- Keywords
- Online Misinformation, Chronic Disease, Medication Adherence
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 402 participants (actual)
- Lead sponsor
- Alexandria UniversityUniversity, hospital or other
- Study start
- 20 May 2026 (actual)
- Primary completion
- 30 Jun 2026 (actual)
- Study completion
- 30 Jul 2026 (actual)
- First posted
- 22 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A cross-sectional analytical study was conducted among adult patients diagnosed with chronic diseases to assess the impact of online medical misinformation on medication adherence, treatment decision-making, and health care-seeking behavior.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Single Cohort: Adults With Chronic Diseases Exposed to Online Medical Information | – | Other: None (observational) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients with chronic diseases attending outpatient clinics, who actively use social media and are exposed to online medical information.
Key inclusion criteria (4 listed)
- Adults ≥ 18 years
- Disease duration ≥ 6 months
- Social media use at least once weekly
- Able to provide informed consent
Key exclusion criteria (1 listed)
- Severe cognitive or psychiatric disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| None (observational)None (observational) | Other | Single Cohort: Adults With Chronic Diseases Exposed to Online Medical Information |
Primary outcome
Medication Adherence (MARS-5 Score)
Time frame: At baseline survey assessment
Description: Measures adherence to prescribed medications
Healthcare-Seeking Behavior Score
Time frame: At baseline survey assessment
Treatment Decision Changes (OHIU-CD Subscale)
Time frame: At baseline survey assessment
Measures changes in treatment decisions influenced by online information
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Aug 2026.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mohamed Fakhry Ahmed Salem, PHD principal investigator
Alexandria University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Medical Misinformation and Medication Adherence, run by Alexandria University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Medication Adherence (MARS-5 Score) (time frame: At baseline survey assessment). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.